化合物DMH-25 T8569
品牌 | 厂商性质 | 产地 | 货期 |
---|---|---|---|
TargetMol | 生产商 | 美国 | 现货 |
性能特点
生化试剂,可用于动物细胞实验
规格 | CAS号 | 价格 | 操作 |
---|---|---|---|
10 mg | 1685280-21-0 | ¥4,320.00 | 询底价 |
1 mL | 1685280-21-0 | ¥3,430.00 | 询底价 |
100 mg | 1685280-21-0 | ¥12,500.00 | 询底价 |
5 mg | 1685280-21-0 | ¥2,920.00 | 询底价 |
2 mg | 1685280-21-0 | ¥1,930.00 | 询底价 |
25 mg | 1685280-21-0 | ¥6,890.00 | 询底价 |
1 mg | 1685280-21-0 | ¥1,290.00 | 询底价 |
50 mg | 1685280-21-0 | ¥9,330.00 | 询底价 |
Product Introduction
Bioactivity
英文名: DMH-25
描述: DMH-25 是一种新型共价有效的 mTOR 抑制剂,在体内对三阴性乳腺癌细胞具有抗肿瘤活性。
体内活性: In vivo, DHM25 was an efficient inhibitor of growth and metastasis of triple-negative breast cancer cells, paving the way for its clinical application in oncology. Constitutive activation of the PI3K/mTOR signaling pathway contributes to carcinogenesis and metastasis in most, if not all, breast cancers.
存储条件: Powder: -20°C for 3 years | In solvent: -80°C for 1 year
溶解度: DMSO : 25 mg/mL (51.03 mM)
关键字: DMH-25 | DMH 25 | DMH25
相关产品: mTOR inhibitor 9e | JR-AB2-011 | P-2281 | GDC0084 | K-7174 dihydrochloride | AZD 3147 | Temsirolimus | 7-(4-Hydroxyphenyl)-1-phenyl-4-hepten-3-one | M2698 | D-α-Hydroxyglutaric acid disodium
相关库: HIF-1 Signaling Pathway Compound Library | Glycometabolism Compound Library | Pyroptosis Compound Library | Neuronal Differentiation Compound Library | Inhibitor Library | Kinase Inhibitor Library | Anti-Diabetic Compound Library | Anti-Cancer Active Compound Library | Autophagy Compound Library | Reprogramming Compound Library
化合物DMH-25 T8569信息由TargetMol中国为您提供,如您想了解更多关于化合物DMH-25 T8569报价、型号、参数等信息,欢迎来电或留言咨询。
注:该产品未在中华人民共和国食品药品监督管理部门申请医疗器械注册和备案,不可用于临床诊断或治疗等相关用途